TRLS — Trellus Health Cashflow Statement
0.000.00%
Last trade - 00:00- £2.66m
- -£3.38m
- $0.02m
- 10
- 26
- 76
- 26
Annual cashflow statement for Trellus Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.762 | -5.9 | -8.81 | -6.8 |
| Depreciation | ||||
| Non-Cash Items | — | 0.139 | 0.185 | 0.265 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.111 | 0.959 | -0.531 | 0.548 |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.65 | -4.77 | -8.62 | -5.27 |
| Capital Expenditures | -0.674 | -3.72 | -2.91 | -2.35 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Cash from Investing Activities | -0.674 | -3.72 | -2.91 | -2.35 |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 5.01 | 38.5 | 0 | 0 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 3.68 | 28.3 | -12.9 | -6.92 |